DOP106 Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn’s Colitis Cure Data Insights Program
Wen‐Yu Su(Liverpool Hospital), Jane M. Andrews(Health Net), Kate D. Lynch(University of Oxford), Ian C. Lawrance(The University of Western Australia), Weng Ng(Sir Run Run Shaw Hospital), G Walker(The University of Queensland), Susan J. Connor(Liverpool Hospital), Edward Giles(Hudson Institute of Medical Research), Yoon‐Kyo An(Mater Hospital), Shoma Dutt(The University of Sydney), Alistair Forbes(University of Otago), Wayne H. Wilson(Lyell McEwin Hospital), Alex Kim(Lawrence Berkeley National Laboratory), L Brett(Logan Hospital), Huan Su(Weihai Science and Technology Bureau)
Cited by 1
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Improved Cosmological Constraints from New, Old, and Combined Supernova Data Sets
|The Astrophysical Journal|2008|1.6k
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252